The genotoxicity of 10 essential oil constituents was evaluated using the Drosophila melanogaster (Meigen) somatic mutation and recombination test, also known as the wing spot test, in the frame of a screening project aiming at evaluating the mutagenic activity of widely used substances, natural or not. Of the compounds that we tested here, L-carveol, dihydrocarveol, (+)-dihydrocarvone, (À)-fenchone and (À)-carvyl acetate did not exhibit any mutagenic or recombinogenic activity, whereas (AE)-linalool, S-(+)-carvone and S-(À)-limonene gave inconclusive results. In contrast, a-phellandrene and R-(À)-carvone significantly increased the frequency of mutant spots when compared with the negative control, suggesting mutagenic activity even at the lowest concentration used (1.5ml/ml). Moreover, these data clearly demonstrate differences in activity between stereoisomers such as S-(+)-and R-(À)-carvone. Given that a-phellandrene and R-(À)-carvone are widely used compounds, further research is needed in order to have a better understanding of their activity and a clearer picture of their genotoxicity in order to decide whether they should remain or not in the lists of compounds that are safe to use. Copyright
The present study provides information for lethal and sublethal effects of spinosad and deltamethrin against a target and a non-target species. Both insecticides can exert high toxicity to B. oleae when adults are exposed even to very low doses for long periods of time. The results contribute to the database on the genotoxic potential of spinosad and deltamethrin, suggesting a safety profile for both insecticides.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.